v3 Template
A

Alis Biosciences

Healthcare and Biotechnology ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$30.0B
Funding Rounds
1
Last Funding
2025-04-18

About Alis Biosciences

Alis Biosciences is a healthcare investment vehicle focused on returning trapped capital and revitalizing viable science and intellectual property in public, development-stage life sciences and biotech companies with negative Enterprise Value. They aim to address market inefficiencies by offering flexible solutions and creating a market safety net for shareholders.

Products & Services

Healthcare Investment Solutions:Collaborative work with listed company shareholders, management, and boards to return trapped capital and resuscitate science and IP in life sciences and biotech firms.

Specialties

Bioscience expertise Healthcare investing Returning trapped capital Revitalizing intellectual property in life sciences

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Fund Launch
T: -
FT: Fund Launch
A: 30000000000
MR: -
FA: over USD$30 billion
FAN: 30000000000
D: 2025-04-18
FD: 2025-04-18
-
Fund Launch Latest
2025-04-18
$30.0B

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Annalisa Jenkins

Chair

N

Nicholas Johnston

Board Member and Founder

I

Ian Stanlake

M

Martin Frenette

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Alis Biosciences Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare and Biotechnology
Company Size
~40 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro